Literature DB >> 6100229

[EGF receptors in human breast cancer. Relation to hormonal receptors].

J P Peyrat, J Bonneterre, B Vandewalle, J Djiane, J Lefebvre.   

Abstract

EGF membrane receptors (R-EGF) were assayed in 65 human breast cancer biopsies. The Scatchard analysis of the binding of 125I-EGF indicated a single class of sites with an apparent dissociation constant of 1 nM. Fourty-eight percent of the tumors are R-EGF positive (specific binding greater than 1% of total radioactivity), the level of receptors reaching 14%. We have not observed any relationship between R-EGF and hormone receptors (estradiol, progesterone and prolactin) or clinical and histological characteristics of the tumor. Taking into account the role of EGF in growth of some human breast cancer epithelial cells culture and the possible production of R-EGF by oncogenes, these results suggest that R-EGF could be an uindependent biochemical marker of human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6100229

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  4 in total

1.  Epidermal growth factor receptor assay: validation of a single point method and application to breast cancer.

Authors:  J L Formento; M Francoual; P Formento; M C Etienne; J L Fischel; M Namer; M Frenay; E François; G Milano
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Estimation of epidermal growth factor receptor in 177 breast cancers: correlation with prognostic factors.

Authors:  M Bolla; M Chedin; C Souvignet; J Marron; C Arnould; E Chambaz
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

3.  Epidermal growth factor receptor in human breast cancers: correlation with estrogen and progesterone receptors.

Authors:  J C Delarue; S Friedman; H Mouriesse; F May-Levin; H Sancho-Garnier; G Contesso
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

4.  Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.

Authors:  G Gasparini; P Bevilacqua; F Pozza; S Meli; P Boracchi; E Marubini; J R Sainsbury
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.